96922-75-7

Upstream product

• 103225-19-0 (S)-2-[((S)-3-Benzoyl-4-benzyl-2,2-dimethyl-oxazolidin-5-ylmethyl)-benzyloxycarbonyl-amino]-propionic acid 2-trimethylsilanyl-ethyl ester 
• 501-53-1 benzyl chloroformate 
• 90656-99-8 (S)-N-[3-Chloro-2-oxo-1-(phenylmethyl)propyl]-benzamide 
• 103225-20-3 (S)-1-{(S)-2-[((S)-3-Benzoyl-4-benzyl-2,2-dimethyl-oxazolidin-5-ylmethyl)-benzyloxycarbonyl-amino]-propionyl}-pyrrolidine-2-carboxylic acid benzyl ester 
• 41324-66-7 H-Pro-OBzl 
• 103225-18-9 (S)-2-[((2R,3S)-3-Benzoylamino-2-hydroxy-4-phenyl-butyl)-benzyloxycarbonyl-amino]-propionic acid 2-trimethylsilanyl-ethyl ester 
• 103225-18-9 (S)-2-[((2S,3S)-3-Benzoylamino-2-hydroxy-4-phenyl-butyl)-benzyloxycarbonyl-amino]-propionic acid 2-trimethylsilanyl-ethyl ester 

Downstream Products

• 96922-62-2 (3S)-1-[N-[3-(benzoylamino)-2-hydroxy-4-phenylbutyl]-L-alanyl]-L-proline, sodium salt 

Relevant academic research and scientific papers

Synthesis of Peptide-Derived Amino Alcohols. 1. Potential Transition-State Inhibitors of Angiotensin Converting Enzyme

Synthetic methods and protection schemes were developed for "peptidyl amino alcohols" in which a novel "amino alcohol" design element is introduced into a peptide backbone to produce a new class of proteolytic enzyme inhibitors.

HYDROXY SUBSTITUTED PEPTIDE COMPOUNDS

Hydroxy substituted peptide compounds of the formula STR1 are disclosed. These compounds are useful as hypotensive agents due to their angiotensin converting enzyme inhibition activity and depending upon the definition of X may also be useful as analgesics due to their enkephalinase inhibition activity.